Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:651-657
Published online before print July 25, 2005, doi: 10.1161/CIRCULATIONAHA.104.529297
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/5/651    most recent
CIRCULATIONAHA.104.529297v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meisinger, C.
Right arrow Articles by Koenig, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meisinger, C.
Right arrow Articles by Koenig, W.
Related Collections
Right arrow Risk Factors
Right arrow Epidemiology
Right arrow Lipid and lipoprotein metabolism

(Circulation. 2005;112:651-657.)
© 2005 American Heart Association, Inc.


Epidemiology

Plasma Oxidized Low-Density Lipoprotein, a Strong Predictor for Acute Coronary Heart Disease Events in Apparently Healthy, Middle-Aged Men From the General Population

Christa Meisinger, MD, MPH; Jens Baumert, MS; Natalie Khuseyinova, MD; Hannelore Loewel, MD; Wolfgang Koenig, MD

From GSF the National Research Center for Environment and Health (C.M., J.B., H.L.), Institute of Epidemiology, Neuherberg; the Central Hospital of Augsburg (C.M., H.L.), MONICA/KORA Myocardial Infarction Registry, Augsburg; and the Department of Internal Medicine II–Cardiology (N.K., W.K), University of Ulm Medical Center, Ulm, Germany.

Correspondence to Prof Wolfgang Koenig, MD, FESC, FACC, Department of Internal Medicine II–Cardiology, University of Ulm Medical Center, Robert-Koch Strasse 8, D-89081 Ulm, Germany. E-mail wolfgang.koenig{at}medizin.uni-ulm.de

Received October 12, 2004; de novo received December 14, 2004; revision received April 6, 2005; accepted April 12, 2005.

Background— Oxidized LDL (oxLDL) is thought to play a key role in the inflammatory response in the arterial vessel wall.

Methods and Results— In a prospective, nested, case-control study, the association between plasma oxLDL and risk of an acute coronary heart disease (CHD) event was investigated in men without prevalent CHD or diabetes mellitus at baseline. Subjects came from 2 population-based MONICA/KORA Augsburg surveys conducted in the years 1989–1990 and 1994–1995 with follow-up in 1998 (mean±SD follow-up time, 5.6±2.6 years). OxLDL was determined by ELISA in 88 men with incident CHD and in 258 age- and survey-matched controls. Hazard ratios (HRs) were estimated from conditional logistic-regression models with matching for age and survey. Baseline mean plasma oxLDL concentrations were significantly higher in subjects who subsequently experienced an event compared with controls (mean±SD, 110±32 versus 93±28 U/L; P≤0.001). After adjustment for smoking, hypertension, obesity, physical activity, education, and alcohol consumption, the HR for a future CHD event in a comparison of the upper tertile of the oxLDL distribution with the lower tertile was 4.25 (95% confidence interval, 2.09 to 8.63; P<0.001). Plasma oxLDL was the strongest predictor of CHD events compared with a conventional lipoprotein profile and other traditional risk factors for CHD. When both oxLDL and C-reactive protein were simultaneously assessed in the same model, they still predicted future CHD events even after multivariable adjustment.

Conclusions— Elevated concentrations of oxLDL are predictive of future CHD events in apparently healthy men. Thus, oxLDL may represent a promising risk marker for clinical CHD complications and should be evaluated in further studies.


Key Words: lipoproteins • inflammation • coronary disease • metabolism • risk factors




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Langlois, E. R. Rietzschel, M. L. De Buyzere, D. De Bacquer, S. Bekaert, V. Blaton, G. G. De Backer, T. C. Gillebert, and on behalf of the Asklepios Investigators
Femoral Plaques Confound the Association of Circulating Oxidized Low-Density Lipoprotein With Carotid Atherosclerosis in a General Population Aged 35 to 55 Years: The Asklepios Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1563 - 1568.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. Lopez-Garcia, R. M. van Dam, T. Y. Li, F. Rodriguez-Artalejo, and F. B. Hu
The Relationship of Coffee Consumption with Mortality
Ann Intern Med, June 17, 2008; 148(12): 904 - 914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Castilla, A. Davalos, J. L. Teruel, F. Cerrato, M. Fernandez-Lucas, J. L. Merino, C. C. Sanchez-Martin, J. Ortuno, and M. A Lasuncion
Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Hansel, C. Nicolle, F. Lalanne, F. Tondu, T. Lassel, Y. Donazzolo, J. Ferrieres, M. Krempf, J.-L. Schlienger, B. Verges, et al.
Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 790 - 796.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kiechl, J. Willeit, M. Mayr, B. Viehweider, M. Oberhollenzer, F. Kronenberg, C. J. Wiedermann, S. Oberthaler, Q. Xu, J. L. Witztum, et al.
Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes: Prospective Results From the Bruneck Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1788 - 1795.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. K. Schindhelm, M. Alssema, P. G. Scheffer, M. Diamant, J. M. Dekker, R. Barto, G. Nijpels, P. J. Kostense, R. J. Heine, C. G. Schalkwijk, et al.
Fasting and Postprandial Glycoxidative and Lipoxidative Stress Are Increased in Women With Type 2 Diabetes
Diabetes Care, July 1, 2007; 30(7): 1789 - 1794.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Fito, M. Guxens, D. Corella, G. Saez, R. Estruch, R. de la Torre, F. Frances, C. Cabezas, M. d. C. Lopez-Sabater, J. Marrugat, et al.
Effect of a Traditional Mediterranean Diet on Lipoprotein Oxidation: A Randomized Controlled Trial
Arch Intern Med, June 11, 2007; 167(11): 1195 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. A Calo, A. Naso, G. Carraro, M. L. Wratten, E. Pagnin, L. Bertipaglia, M. Rebeschini, P. A Davis, A. Piccoli, and C. Cascone
Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1413 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Koenig and N. Khuseyinova
Biomarkers of Atherosclerotic Plaque Instability and Rupture
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Lopez-Garcia, R. M van Dam, L. Qi, and F. B Hu
Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 888 - 893.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Wu, W. C. Willett, N. Rifai, I. Shai, J. E. Manson, and E. B. Rimm
Is Plasma Oxidized Low-Density Lipoprotein, Measured With the Widely Used Antibody 4E6, an Independent Predictor of Coronary Heart Disease Among U.S. Men and Women?
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 973 - 979.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M.-I. Covas, K. Nyyssonen, H. E. Poulsen, J. Kaikkonen, H.-J. F. Zunft, H. Kiesewetter, A. Gaddi, R. de la Torre, J. Mursu, H. Baumler, et al.
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial.
Ann Intern Med, September 5, 2006; 145(5): 333 - 341.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. S. Vasan
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Circulation, May 16, 2006; 113(19): 2335 - 2362.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Holvoet, E. Macy, M. Landeloos, D. Jones, J. S. Nancy, F. Van de Werf, and R. P. Tracy
Analytical Performance and Diagnostic Accuracy of Immunometric Assays for the Measurement of Circulating Oxidized LDL
Clin. Chem., April 1, 2006; 52(4): 760 - 764.
[Abstract] [Full Text] [PDF]